The risk or severity of adverse effects can be increased when Olsalazine is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when diclofenac is combined with estrone.


The risk or severity of adverse effects can be increased when Amrinone is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when isoflurane is combined with labetalol.


The risk or severity of adverse effects can be increased when isoflurane is combined with thiopental.


The risk or severity of adverse effects can be increased when propranolol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when isoflurane is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when propranolol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when isoflurane is combined with ethosuximide.


The risk or severity of adverse effects can be increased when isoflurane is combined with doxazosin.


The risk or severity of adverse effects can be increased when DESONIDE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when trandolapril is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with zotepine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when DESONIDE is combined with physostigmine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with indapamide.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with etodolac.


The risk or severity of adverse effects can be increased when methysergide is combined with oxybutynin.


The risk or severity of adverse effects can be increased when metoprolol is combined with nadolol.


The risk or severity of adverse effects can be increased when risperidone is combined with prilocaine.


The risk or severity of adverse effects can be increased when tizanidine is combined with bumetanide.


The risk or severity of adverse effects can be increased when sulindac is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when tizanidine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when tizanidine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when zaleplon is combined with Iloperidone.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with nadolol.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when midazolam is combined with sulpiride.


The risk or severity of adverse effects can be increased when leflunomide is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when docetaxel is combined with Pazopanib.


The risk or severity of adverse effects can be increased when fosinopril is combined with carvedilol.


The risk or severity of adverse effects can be increased when fosinopril is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with leflunomide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with halothane.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with MELPERONE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with thiopental.


The risk or severity of adverse effects can be increased when prilocaine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with hydralazine.


The risk or severity of adverse effects can be increased when thiothixene is combined with Perospirone.


The risk or severity of adverse effects can be increased when methazolamide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with etodolac.


The risk or severity of adverse effects can be increased when nilvadipine is combined with tizanidine.


The risk or severity of adverse effects can be increased when nilvadipine is combined with furosemide.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with zotepine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when protriptyline is combined with naratriptan.


The risk or severity of adverse effects can be increased when protriptyline is combined with rizatriptan.


The risk or severity of adverse effects can be increased when protriptyline is combined with fexofenadine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Normethadone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when promazine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ketamine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when triazolam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when naratriptan is combined with sulpiride.


The risk or severity of adverse effects can be increased when ketamine is combined with sulpiride.


The risk or severity of adverse effects can be increased when trimipramine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Pentolinium is combined with methadone.


The risk or severity of adverse effects can be increased when Almotriptan is combined with rasagiline.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Clobetasone.


The risk or severity of adverse effects can be increased when acemetacin is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when bromazepam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when bromazepam is combined with glutethimide.


The risk or severity of adverse effects can be increased when ketoprofen is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with doxepin.


The risk or severity of adverse effects can be increased when indapamide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when codeine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when butalbital is combined with imipramine.


The risk or severity of adverse effects can be increased when zotepine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with budesonide.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when loxapine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Pizotifen.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with D-mannitol.


The risk or severity of adverse effects can be increased when secobarbital is combined with cocaine.


The risk or severity of adverse effects can be increased when proparacaine is combined with halothane.


The risk or severity of adverse effects can be increased when Normethadone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with nadolol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with penbutolol.


The risk or severity of adverse effects can be increased when temazepam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when temazepam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when triazolam is combined with glutethimide.


The risk or severity of adverse effects can be increased when cocaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when moclobemide is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when moclobemide is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when triazolam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when oxymorphone is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with alclometasone.


The risk or severity of adverse effects can be increased when moclobemide is combined with metoclopramide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when secobarbital is combined with tiagabine.


The risk or severity of adverse effects can be increased when estriol is combined with Ospemifene.


The risk or severity of adverse effects can be increased when mafenide is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with flunisolide.


The risk or severity of adverse effects can be increased when oxycodone is combined with tiapride.


The risk or severity of adverse effects can be increased when meperidine is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when benzocaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with flunisolide.


The risk or severity of adverse effects can be increased when QUINETHAZONE is combined with ouabain.


The risk or severity of adverse effects can be increased when azelastine is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Pizotifen is combined with venlafaxine.


The risk or severity of adverse effects can be increased when secobarbital is combined with fexofenadine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Nilotinib.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when benzocaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when codeine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when codeine is combined with pargyline.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when codeine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with vigabatrin.


The risk or severity of adverse effects can be increased when codeine is combined with thiothixene.


The risk or severity of adverse effects can be increased when flurazepam is combined with dyclonine.


The risk or severity of adverse effects can be increased when flurazepam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when sulindac is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when meclizine is combined with maprotiline.


The risk or severity of adverse effects can be increased when meperidine is combined with linezolid.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with baclofen.


The risk or severity of adverse effects can be increased when doxylamine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when clomipramine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when morphine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when morphine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with atenolol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Conivaptan is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when methazolamide is combined with metformin.


The risk or severity of adverse effects can be increased when scopolamine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Naftifine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with methyldopa.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when etizolam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when etizolam is combined with duloxetine.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when phenytoin is combined with ethotoin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with cabergoline.


The risk or severity of adverse effects can be increased when butabarbital is combined with haloperidol.


The risk or severity of adverse effects can be increased when triprolidine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when terconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when chloroquine is combined with halcinonide.


The risk or severity of adverse effects can be increased when chloroquine is combined with difluprednate.


The risk or severity of adverse effects can be increased when butalbital is combined with Olopatadine.


The risk or severity of adverse effects can be increased when hydralazine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Eprosartan is combined with salicylamide.


The risk or severity of adverse effects can be increased when alprazolam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Etomidate is combined with baclofen.


The risk or severity of adverse effects can be increased when fludiazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when triazolam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Perospirone is combined with Normethadone.


The risk or severity of adverse effects can be increased when isoflurane is combined with topiramate.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with oxprenolol.


The risk or severity of adverse effects can be increased when isoflurane is combined with isradipine.


The risk or severity of adverse effects can be increased when apomorphine is combined with bumetanide.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when isoflurane is combined with Olmesartan.


The risk or severity of adverse effects can be increased when celecoxib is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with prazepam.


The risk or severity of adverse effects can be increased when ipratropium is combined with morphine.


The risk or severity of adverse effects can be increased when clozapine is combined with Torasemide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Torasemide.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with Echothiophate.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when bumetanide is combined with deslanoside.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with benzocaine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with dibucaine.


The risk or severity of adverse effects can be increased when triamterene is combined with nifedipine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with tiapride.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with butamben.


The risk or severity of adverse effects can be increased when fosinopril is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when medrysone is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Pinaverium is combined with fluvastatin.


The risk or severity of adverse effects can be increased when amiodarone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with metolazone.


The risk or severity of adverse effects can be increased when gabapentin is combined with tiagabine.


The risk or severity of adverse effects can be increased when gabapentin is combined with cocaine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with floctafenine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with butorphanol.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with clonazepam.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with promethazine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with topiramate.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with difluprednate.


The risk or severity of adverse effects can be increased when Talniflumate is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when flurazepam is combined with oxymorphone.


The risk or severity of adverse effects can be increased when Tramadol is combined with cetirizine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when flurazepam is combined with zopiclone.


The risk or severity of adverse effects can be increased when antipyrine is combined with difluprednate.


The risk or severity of adverse effects can be increased when glutethimide is combined with desipramine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with rasagiline.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Pinaverium.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when vinorelbine is combined with leflunomide.


The risk or severity of adverse effects can be increased when ramipril is combined with Salsalate.


The risk or severity of adverse effects can be increased when nicergoline is combined with midazolam.


The risk or severity of adverse effects can be increased when ipratropium is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with pentazocine.


The risk or severity of adverse effects can be increased when halothane is combined with fludiazepam.


The risk or severity of adverse effects can be increased when buspirone is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Halazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when butenafine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Propiverine.


The risk or severity of adverse effects can be increased when butenafine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when butenafine is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when butenafine is combined with Benidipine.


The risk or severity of adverse effects can be increased when halothane is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when meclizine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Tapentadol is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when Tapentadol is combined with polythiazide.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with oxycodone.


The risk or severity of adverse effects can be increased when Toloxatone is combined with dobutamine.


The risk or severity of adverse effects can be increased when oxycodone is combined with maprotiline.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when clorazepate is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when ethyl icosapentate is combined with Apixaban.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when terbinafine is combined with nimodipine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with bupivacaine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Etomidate.


The risk or severity of adverse effects can be increased when triazolam is combined with triprolidine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with ATROPINE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with procarbazine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with sevoflurane.


The risk or severity of adverse effects can be increased when valsartan is combined with carprofen.


The risk or severity of adverse effects can be increased when buspirone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when meperidine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with desipramine.


The risk or severity of adverse effects can be increased when Salsalate is combined with flunisolide.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when dyclonine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Tramadol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when reserpine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with clomipramine.


The risk or severity of adverse effects can be increased when buspirone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when amoxapine is combined with clomipramine.


The risk or severity of adverse effects can be increased when reserpine is combined with scopolamine.


The risk or severity of adverse effects can be increased when quazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when thiothixene is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when quinapril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Levocetirizine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Tramadol is combined with glutethimide.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with scopolamine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with phenazopyridine.


The risk or severity of adverse effects can be increased when meperidine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when epoprostenol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when brotizolam is combined with primidone.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ropinirole is combined with Riociguat.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with METAXALONE.


The risk or severity of adverse effects can be increased when flurazepam is combined with quetiapine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when flurazepam is combined with ketamine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when doxazosin is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when eperisone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when epinastine is combined with salicylic acid.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when bepridil is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with flunarizine.


The risk or severity of adverse effects can be increased when enflurane is combined with nefazodone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when alprazolam is combined with sevoflurane.


The risk or severity of adverse effects can be increased when morphine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with triprolidine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when halothane is combined with triamterene.


The risk or severity of adverse effects can be increased when enflurane is combined with Tolcapone.


The risk or severity of adverse effects can be increased when enflurane is combined with amitriptyline.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with zotepine.


The risk or severity of adverse effects can be increased when quetiapine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when halothane is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when butorphanol is combined with maprotiline.


The risk or severity of adverse effects can be increased when tolterodine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when estazolam is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when thioridazine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when diazepam is combined with Butethal.


The risk or severity of adverse effects can be increased when temazepam is combined with gabapentin.


The risk or severity of adverse effects can be increased when diazepam is combined with amobarbital.


The risk or severity of adverse effects can be increased when propofol is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when loratadine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when loteprednol is combined with rivastigmine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Retigabine.


The risk or severity of adverse effects can be increased when risperidone is combined with bromazepam.


The risk or severity of adverse effects can be increased when furosemide is combined with plicamycin.


The risk or severity of adverse effects can be increased when barnidipine is combined with betaxolol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when clorazepate is combined with brotizolam.


The risk or severity of adverse effects can be increased when benazepril is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with scopolamine.


The risk or severity of adverse effects can be increased when codeine is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when ketorolac is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when enflurane is combined with Normethadone.


The risk or severity of adverse effects can be increased when imipramine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when carbamazepine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Lofexidine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when suprofen is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when nicergoline is combined with metronidazole.


The risk or severity of adverse effects can be increased when nicergoline is combined with Repaglinide.


The risk or severity of adverse effects can be increased when carisoprodol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when clidinium is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when enflurane is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with thioridazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with oxybutynin.


The risk or severity of adverse effects can be increased when cabergoline is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when thiothixene is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when memantine is combined with Varenicline.


The risk or severity of adverse effects can be increased when methysergide is combined with desipramine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with zidovudine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with leflunomide.


The risk or severity of adverse effects can be increased when sulpiride is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Treprostinil is combined with tolmetin.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with flunarizine.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with clomipramine.


The risk or severity of adverse effects can be increased when baclofen is combined with Tolcapone.


The risk or severity of adverse effects can be increased when baclofen is combined with amitriptyline.


The risk or severity of adverse effects can be increased when zonisamide is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with estazolam.


The risk or severity of adverse effects can be increased when Lurasidone is combined with enflurane.


The risk or severity of adverse effects can be increased when Flupentixol is combined with brotizolam.


The risk or severity of adverse effects can be increased when nisoldipine is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when diclofenac is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when morphine is combined with propranolol.


The risk or severity of adverse effects can be increased when benazepril is combined with mecamylamine.


The risk or severity of adverse effects can be increased when morphine is combined with clonidine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with PARALDEHYDE.


The risk or severity of adverse effects can be increased when temazepam is combined with sulpiride.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when linezolid is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with alclometasone.


The risk or severity of adverse effects can be increased when meprobamate is combined with midazolam.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Rufinamide is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when celecoxib is combined with nimesulide.


The risk or severity of adverse effects can be increased when temazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when primidone is combined with maprotiline.


The risk or severity of adverse effects can be increased when dyclonine is combined with ethotoin.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with labetalol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with tetracaine.


The risk or severity of adverse effects can be increased when methadone is combined with Efonidipine.


The risk or severity of adverse effects can be increased when lithium ion is combined with cetirizine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with doxazosin.


The risk or severity of adverse effects can be increased when levorphanol is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when flumethasone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with labetalol.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with morphine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Torasemide.


The risk or severity of adverse effects can be increased when reserpine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when thiothixene is combined with butalbital.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when mesalamine is combined with dorzolamide.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with cetirizine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Tramadol is combined with Drospirenone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with protriptyline.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Ibrutinib.


The risk or severity of adverse effects can be increased when Tolcapone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when meprobamate is combined with ketamine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with quinidine.


The risk or severity of adverse effects can be increased when meprobamate is combined with quetiapine.


The risk or severity of adverse effects can be increased when diflunisal is combined with flunisolide.


The risk or severity of adverse effects can be increased when Clevidipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when quazepam is combined with proparacaine.


The risk or severity of adverse effects can be increased when etodolac is combined with formestane.


The risk or severity of adverse effects can be increased when nitric oxide is combined with rasagiline.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with rivastigmine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when docetaxel is combined with nilutamide.


The risk or severity of adverse effects can be increased when cabergoline is combined with Sorafenib.


The risk or severity of adverse effects can be increased when thioridazine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when diltiazem is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when bromazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when lorazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when lorazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when reserpine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when reserpine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when rapamycin is combined with cinnarizine.


The risk or severity of adverse effects can be increased when lorazepam is combined with quazepam.


The risk or severity of adverse effects can be increased when olanzapine is combined with zopiclone.


The risk or severity of adverse effects can be increased when desoximetasone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when pargyline is combined with bezafibrate.


The risk or severity of adverse effects can be increased when tetracaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with cocaine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with tiagabine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with chloroquine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with ondansetron.


The risk or severity of adverse effects can be increased when propoxyphene is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when reserpine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when alprazolam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when reserpine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when reserpine is combined with bumetanide.


The risk or severity of adverse effects can be increased when Canagliflozin is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with zonisamide.


The risk or severity of adverse effects can be increased when fenoprofen is combined with sulindac.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with proparacaine.


The risk or severity of adverse effects can be increased when primidone is combined with paroxetine.


The risk or severity of adverse effects can be increased when Tiotropium is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Halazepam.


The risk or severity of adverse effects can be increased when lithium ion is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when meclizine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when tizanidine is combined with terazosin.


The risk or severity of adverse effects can be increased when promazine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when imipramine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when promazine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with lidocaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Perospirone.


The risk or severity of adverse effects can be increased when nimodipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when nimesulide is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with flunarizine.


The risk or severity of adverse effects can be increased when buprenorphine is combined with selegiline.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when CALCIUM CHLORIDE is combined with Paricalcitol.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with decamethonium.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with amcinonide.


The risk or severity of adverse effects can be increased when thiothixene is combined with maprotiline.


The risk or severity of adverse effects can be increased when thiothixene is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with isradipine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with loteprednol.


The risk or severity of adverse effects can be increased when carprofen is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when temazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Raltitrexed is combined with clozapine.


The risk or severity of adverse effects can be increased when bumetanide is combined with papaverine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with felodipine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with prilocaine.


The risk or severity of adverse effects can be increased when docetaxel is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when nitrazepam is combined with ethotoin.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with carvedilol.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with thiothixene.


The risk or severity of adverse effects can be increased when oxaprozin is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when paroxetine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when sulpiride is combined with oxprenolol.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Fospropofol.


The risk or severity of adverse effects can be increased when reserpine is combined with enflurane.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Olopatadine is combined with difluprednate.


The risk or severity of adverse effects can be increased when Olopatadine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when sulpiride is combined with prazepam.


The risk or severity of adverse effects can be increased when Olopatadine is combined with halcinonide.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with loteprednol.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Clevidipine.


The risk or severity of adverse effects can be increased when butorphanol is combined with pentazocine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with epirizole.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with levorphanol.


The risk or severity of adverse effects can be increased when Pentolinium is combined with pentazocine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with papaverine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with HEROIN.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with nylidrin.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with oxymorphone.


The risk or severity of adverse effects can be increased when promazine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when promazine is combined with dyclonine.


The risk or severity of adverse effects can be increased when Etomidate is combined with tiapride.


The risk or severity of adverse effects can be increased when MELPERONE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Halazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with acetylcholine.


The risk or severity of adverse effects can be increased when methysergide is combined with fluoxetine.


The risk or severity of adverse effects can be increased when pentazocine is combined with clidinium.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with enalapril.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with protriptyline.


The risk or severity of adverse effects can be increased when sertraline is combined with Perospirone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with cetirizine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with prednisone.


The risk or severity of adverse effects can be increased when levorphanol is combined with nortriptyline.


The risk or severity of adverse effects can be increased when levorphanol is combined with amoxapine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when trazodone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when aspirin is combined with rosiglitazone.


The risk or severity of adverse effects can be increased when lorazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when naratriptan is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when imipramine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when diflunisal is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Melatonin is combined with topiramate.


The risk or severity of adverse effects can be increased when enalapril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when haloperidol is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when promazine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when enalapril is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when butalbital is combined with tizanidine.


The risk or severity of adverse effects can be increased when atenolol is combined with bumetanide.


The risk or severity of adverse effects can be increased when perphenazine is combined with topiramate.


The risk or severity of adverse effects can be increased when atenolol is combined with quinapril.


The risk or severity of adverse effects can be increased when atenolol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when nabumetone is combined with fenoprofen.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when loratadine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when fosinopril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with captopril.


The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Carbetocin is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with glutethimide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with omeprazole.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when midodrine is combined with norepinephrine.


The risk or severity of adverse effects can be increased when clemastine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when dipyridamole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when olanzapine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when enalapril is combined with fenbufen.


The risk or severity of adverse effects can be increased when olanzapine is combined with dyclonine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with flunisolide.


The risk or severity of adverse effects can be increased when acebutolol is combined with quetiapine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with rivastigmine.


The risk or severity of adverse effects can be increased when tirofiban is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with physostigmine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when prilocaine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when cytarabine is combined with clozapine.


The risk or severity of adverse effects can be increased when meperidine is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when methadone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with tizanidine.


The risk or severity of adverse effects can be increased when ethanol is combined with trazodone.


The risk or severity of adverse effects can be increased when loteprednol is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with meperidine.


The risk or severity of adverse effects can be increased when loteprednol is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when Articaine is combined with loratadine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with sulpiride.


The risk or severity of adverse effects can be increased when nicardipine is combined with cilazapril.


The risk or severity of adverse effects can be increased when rizatriptan is combined with MELPERONE.


The risk or severity of adverse effects can be increased when naratriptan is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when olanzapine is combined with tetracaine.


The risk or severity of adverse effects can be increased when zolpidem is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Sacubitril is combined with irbesartan.


The risk or severity of adverse effects can be increased when nabumetone is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when losartan is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with prilocaine.


The risk or severity of adverse effects can be increased when Spirapril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when clonazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when prazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with pimozide.


The risk or severity of adverse effects can be increased when Cariprazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when methylergonovine is combined with thiopental.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Apremilast.


The risk or severity of adverse effects can be increased when Pirlindole is combined with bezafibrate.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when ethotoin is combined with sertraline.


The risk or severity of adverse effects can be increased when Spirapril is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when butalbital is combined with nefazodone.


The risk or severity of adverse effects can be increased when rasagiline is combined with triamterene.


The risk or severity of adverse effects can be increased when meperidine is combined with tetracaine.


The risk or severity of adverse effects can be increased when amifostine is combined with tizanidine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with pramipexole.


The risk or severity of adverse effects can be increased when amifostine is combined with furosemide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with rabeprazole.


The risk or severity of adverse effects can be increased when LISURIDE is combined with bicalutamide.


The risk or severity of adverse effects can be increased when butabarbital is combined with Pramocaine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with D-mannitol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when butabarbital is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with tetracaine.


The risk or severity of adverse effects can be increased when secobarbital is combined with chlormezanone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when benztropine is combined with morphine.


The risk or severity of adverse effects can be increased when atenolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with epirizole.


The risk or severity of adverse effects can be increased when secobarbital is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when perphenazine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when triamterene is combined with benazepril.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with dipyridamole.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Tixocortol.


The risk or severity of adverse effects can be increased when olanzapine is combined with Perospirone.


The risk or severity of adverse effects can be increased when barnidipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when thiopental is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with estazolam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Olmesartan is combined with triamterene.


The risk or severity of adverse effects can be increased when risperidone is combined with zonisamide.


The risk or severity of adverse effects can be increased when cilazapril is combined with Clevidipine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Icatibant is combined with leflunomide.


The risk or severity of adverse effects can be increased when codeine is combined with indapamide.


The risk or severity of adverse effects can be increased when LISURIDE is combined with modafinil.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with tiapride.


The risk or severity of adverse effects can be increased when codeine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when codeine is combined with Halazepam.


The risk or severity of adverse effects can be increased when codeine is combined with proparacaine.


The risk or severity of adverse effects can be increased when risperidone is combined with proparacaine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with terazosin.


The risk or severity of adverse effects can be increased when valsartan is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when bepridil is combined with isoflurane.


The risk or severity of adverse effects can be increased when Butethal is combined with lithium ion.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when indomethacin is combined with alclofenac.


The risk or severity of adverse effects can be increased when bepridil is combined with tretinoin.


The risk or severity of adverse effects can be increased when isoflurane is combined with Aliskiren.


The risk or severity of adverse effects can be increased when ropinirole is combined with trandolapril.


The risk or severity of adverse effects can be increased when HEROIN is combined with metolazone.


The risk or severity of adverse effects can be increased when promazine is combined with zopiclone.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with nefazodone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Flupentixol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with procarbazine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with aspirin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with flunarizine.


The risk or severity of adverse effects can be increased when clemastine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when morniflumate is combined with epirizole.


The risk or severity of adverse effects can be increased when procaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Fospropofol is combined with maprotiline.


The risk or severity of adverse effects can be increased when pancuronium is combined with Normethadone.


The risk or severity of adverse effects can be increased when procaine is combined with clonidine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when cabergoline is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when nicergoline is combined with amprenavir.


The risk or severity of adverse effects can be increased when bupivacaine is combined with epoprostenol.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with amcinonide.


The risk or severity of adverse effects can be increased when tolterodine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Vilazodone.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when actinomycin D is combined with clozapine.


The risk or severity of adverse effects can be increased when procarbazine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when tioconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when prednisone is combined with leflunomide.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with thioridazine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with rasagiline.


The risk or severity of adverse effects can be increased when diclofenac is combined with alclofenac.


The risk or severity of adverse effects can be increased when amoxapine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when tioconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with ethosuximide.


The risk or severity of adverse effects can be increased when cabergoline is combined with azelastine.


The risk or severity of adverse effects can be increased when alprazolam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with triflupromazine.


The risk or severity of adverse effects can be increased when trazodone is combined with butamben.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when fenoldopam is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when meperidine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when irbesartan is combined with nimesulide.


The risk or severity of adverse effects can be increased when protriptyline is combined with promethazine.


The risk or severity of adverse effects can be increased when protriptyline is combined with clonazepam.


The risk or severity of adverse effects can be increased when sumatriptan is combined with bromocriptine.


The risk or severity of adverse effects can be increased when loxapine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when loxapine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when loxapine is combined with zaleplon.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when tolazoline is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when protriptyline is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with edrophonium.


The risk or severity of adverse effects can be increased when floctafenine is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when docetaxel is combined with vindesine.


The risk or severity of adverse effects can be increased when clopidogrel is combined with aspirin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when docetaxel is combined with mitomycin C.


The risk or severity of adverse effects can be increased when nitric oxide is combined with enalapril.


The risk or severity of adverse effects can be increased when docetaxel is combined with Bexarotene.


The risk or severity of adverse effects can be increased when donepezil is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when meclizine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with fenbufen.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Escitalopram.


The risk or severity of adverse effects can be increased when valsartan is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Etomidate is combined with lithium ion.


The risk or severity of adverse effects can be increased when bupivacaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when bupivacaine is combined with benazepril.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Etomidate is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with levorphanol.


The risk or severity of adverse effects can be increased when oxycodone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when fludiazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with doxepin.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when pimozide is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with indapamide.


The risk or severity of adverse effects can be increased when pimozide is combined with Butethal.


The risk or severity of adverse effects can be increased when estrone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when pimozide is combined with amobarbital.


The risk or severity of adverse effects can be increased when reserpine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when nicotinamide is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when Isoflurophate is combined with meperidine.


The risk or severity of adverse effects can be increased when labetalol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Asenapine is combined with thiamylal.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Asenapine is combined with halothane.


The risk or severity of adverse effects can be increased when diclofenac is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when diclofenac is combined with Halobetasol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with amitriptyline.


The risk or severity of adverse effects can be increased when zaleplon is combined with dyclonine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Tolcapone.


The risk or severity of adverse effects can be increased when zaleplon is combined with propoxyphene.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with papaverine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with flunarizine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when losartan is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when prilocaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when terbinafine is combined with Benidipine.


The risk or severity of adverse effects can be increased when terbinafine is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when terbinafine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when terbinafine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when brotizolam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when carbamazepine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when dibucaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with diltiazem.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Articaine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with citalopram.


The risk or severity of adverse effects can be increased when carbamazepine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when naratriptan is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when trimipramine is combined with scopolamine.


The risk or severity of adverse effects can be increased when temazepam is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when prazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when ketoprofen is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Tramadol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when protriptyline is combined with Indacaterol.


The risk or severity of adverse effects can be increased when bromazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when etodolac is combined with carprofen.


The risk or severity of adverse effects can be increased when vigabatrin is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Lacidipine.


The risk or severity of adverse effects can be increased when vigabatrin is combined with duloxetine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with nadolol.


The risk or severity of adverse effects can be increased when maprotiline is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when maprotiline is combined with Ramelteon.


The risk or severity of adverse effects can be increased when meperidine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when procyclidine is combined with Trospium.


The risk or severity of adverse effects can be increased when dyclonine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when carbamazepine is combined with baclofen.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when carbamazepine is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when reserpine is combined with Normethadone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when doxepin is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when valsartan is combined with isradipine.


The risk or severity of adverse effects can be increased when valsartan is combined with Olmesartan.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when maprotiline is combined with clonazepam.


The risk or severity of adverse effects can be increased when secobarbital is combined with levorphanol.


The risk or severity of adverse effects can be increased when midodrine is combined with metaraminol.


The risk or severity of adverse effects can be increased when Normethadone is combined with topiramate.


The risk or severity of adverse effects can be increased when ondansetron is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when diltiazem is combined with oxycodone.


The risk or severity of adverse effects can be increased when sulindac is combined with alclometasone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with carisoprodol.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Apixaban.


The risk or severity of adverse effects can be increased when Salsalate is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when etizolam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Tramadol is combined with maprotiline.


The risk or severity of adverse effects can be increased when captopril is combined with azelastine.


The risk or severity of adverse effects can be increased when risperidone is combined with topiramate.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with betamethasone.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Etomidate.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with alclometasone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cladribine.


The risk or severity of adverse effects can be increased when pentazocine is combined with imipramine.


The risk or severity of adverse effects can be increased when pentazocine is combined with loratadine.


The risk or severity of adverse effects can be increased when floctafenine is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Agomelatine.


The risk or severity of adverse effects can be increased when pergolide is combined with tioconazole.


The risk or severity of adverse effects can be increased when pergolide is combined with Salbutamol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with clemastine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with lidocaine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with hydralazine.


The risk or severity of adverse effects can be increased when oxazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when fosinopril is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when amisulpride is combined with imipramine.


The risk or severity of adverse effects can be increased when morniflumate is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when clomipramine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when ketamine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Apremilast is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when dyclonine is combined with clonidine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Apremilast is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Torasemide is combined with acebutolol.


The risk or severity of adverse effects can be increased when PROCATEROL is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when Torasemide is combined with captopril.


The risk or severity of adverse effects can be increased when phenobarbital is combined with tizanidine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with bumetanide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when propantheline is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when miconazole is combined with nitrendipine.


The risk or severity of adverse effects can be increased when miconazole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with triamterene.


The risk or severity of adverse effects can be increased when nisoldipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when selegiline is combined with propranolol.


The risk or severity of adverse effects can be increased when citalopram is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when selegiline is combined with clonidine.


The risk or severity of adverse effects can be increased when clozapine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when celecoxib is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when clozapine is combined with nimodipine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when risperidone is combined with Retigabine.


The risk or severity of adverse effects can be increased when gabapentin is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with nortriptyline.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with benazepril.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with amoxapine.


The risk or severity of adverse effects can be increased when Halazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Pirlindole is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with dipyridamole.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with etizolam.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when Etomidate is combined with Iloperidone.


The risk or severity of adverse effects can be increased when sulpiride is combined with Tolcapone.


The risk or severity of adverse effects can be increased when sulpiride is combined with amitriptyline.


The risk or severity of adverse effects can be increased when estazolam is combined with Paliperidone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with nimesulide.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with sulpiride.


The risk or severity of adverse effects can be increased when dyclonine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when thioridazine is combined with topiramate.


The risk or severity of adverse effects can be increased when phentolamine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when thioridazine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when fenbufen is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Apremilast.


The risk or severity of adverse effects can be increased when procaine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with benzocaine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with sumatriptan.


The risk or severity of adverse effects can be increased when methadone is combined with potassium ion.


The risk or severity of adverse effects can be increased when midazolam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Olsalazine.


The risk or severity of adverse effects can be increased when midazolam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when selegiline is combined with quetiapine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when pentazocine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with brotizolam.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when halcinonide is combined with decamethonium.


The risk or severity of adverse effects can be increased when morphine is combined with trimipramine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with sildenafil.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Desloratadine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with reserpine.


The risk or severity of adverse effects can be increased when midazolam is combined with Normethadone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with loratadine.


The risk or severity of adverse effects can be increased when loratadine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with imipramine.


The risk or severity of adverse effects can be increased when Salsalate is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Salsalate is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Pizotifen.


The risk or severity of adverse effects can be increased when loratadine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when fluoxetine is combined with periciazine.


The risk or severity of adverse effects can be increased when propofol is combined with ethotoin.


The risk or severity of adverse effects can be increased when propofol is combined with tretinoin.